Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6627 |
Remote Similarity |
NPD568 |
Approved |
0.6627 |
Remote Similarity |
NPD566 |
Approved |
0.6627 |
Remote Similarity |
NPD567 |
Approved |
0.6612 |
Remote Similarity |
NPD3432 |
Approved |
0.6545 |
Remote Similarity |
NPD875 |
Clinical (unspecified phase) |
0.6527 |
Remote Similarity |
NPD174 |
Discontinued |
0.6519 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6416 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6408 |
Remote Similarity |
NPD1623 |
Approved |
0.64 |
Remote Similarity |
NPD3840 |
Phase 2 |
0.64 |
Remote Similarity |
NPD3839 |
Phase 2 |
0.6364 |
Remote Similarity |
NPD2881 |
Approved |
0.6364 |
Remote Similarity |
NPD2879 |
Approved |
0.6349 |
Remote Similarity |
NPD1308 |
Approved |
0.6321 |
Remote Similarity |
NPD3431 |
Approved |
0.6321 |
Remote Similarity |
NPD3430 |
Approved |
0.6319 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.6305 |
Remote Similarity |
NPD5072 |
Discontinued |
0.6304 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.6304 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.629 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6289 |
Remote Similarity |
NPD460 |
Discontinued |
0.628 |
Remote Similarity |
NPD7471 |
Discontinued |
0.6238 |
Remote Similarity |
NPD3905 |
Phase 3 |
0.6232 |
Remote Similarity |
NPD2412 |
Clinical (unspecified phase) |
0.6214 |
Remote Similarity |
NPD4341 |
Clinical (unspecified phase) |
0.6202 |
Remote Similarity |
NPD8271 |
Discontinued |
0.618 |
Remote Similarity |
NPD2604 |
Approved |
0.6178 |
Remote Similarity |
NPD2814 |
Clinical (unspecified phase) |
0.6168 |
Remote Similarity |
NPD9628 |
Approved |
0.6154 |
Remote Similarity |
NPD5974 |
Approved |
0.6154 |
Remote Similarity |
NPD5973 |
Phase 2 |
0.6146 |
Remote Similarity |
NPD4940 |
Approved |
0.6139 |
Remote Similarity |
NPD2130 |
Discontinued |
0.6133 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6119 |
Remote Similarity |
NPD2807 |
Discontinued |
0.6111 |
Remote Similarity |
NPD1952 |
Discontinued |
0.6105 |
Remote Similarity |
NPD9627 |
Approved |
0.6103 |
Remote Similarity |
NPD1286 |
Suspended |
0.6099 |
Remote Similarity |
NPD418 |
Approved |
0.6098 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6071 |
Remote Similarity |
NPD9133 |
Approved |
0.6067 |
Remote Similarity |
NPD1257 |
Approved |
0.6067 |
Remote Similarity |
NPD2660 |
Approved |
0.6067 |
Remote Similarity |
NPD2662 |
Approved |
0.6065 |
Remote Similarity |
NPD7888 |
Approved |
0.6065 |
Remote Similarity |
NPD7887 |
Approved |
0.6062 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.6062 |
Remote Similarity |
NPD5757 |
Discontinued |
0.6058 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.6051 |
Remote Similarity |
NPD5686 |
Approved |
0.6051 |
Remote Similarity |
NPD5685 |
Approved |
0.6049 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6034 |
Remote Similarity |
NPD3906 |
Approved |
0.6033 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6031 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6029 |
Remote Similarity |
NPD2008 |
Discontinued |
0.6022 |
Remote Similarity |
NPD1869 |
Phase 2 |
0.6011 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6011 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.601 |
Remote Similarity |
NPD978 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD3697 |
Discontinued |
0.6 |
Remote Similarity |
NPD5016 |
Approved |
0.5991 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD2137 |
Approved |
0.599 |
Remote Similarity |
NPD2138 |
Approved |
0.5988 |
Remote Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD4446 |
Approved |
0.598 |
Remote Similarity |
NPD7103 |
Approved |
0.598 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.5979 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.5972 |
Remote Similarity |
NPD5887 |
Clinical (unspecified phase) |
0.597 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.5968 |
Remote Similarity |
NPD2333 |
Discontinued |
0.5961 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.5947 |
Remote Similarity |
NPD4155 |
Approved |
0.5942 |
Remote Similarity |
NPD1600 |
Suspended |
0.5939 |
Remote Similarity |
NPD1658 |
Discontinued |
0.5938 |
Remote Similarity |
NPD1233 |
Suspended |
0.5933 |
Remote Similarity |
NPD2411 |
Approved |
0.5932 |
Remote Similarity |
NPD962 |
Phase 3 |
0.592 |
Remote Similarity |
NPD1249 |
Clinical (unspecified phase) |
0.5918 |
Remote Similarity |
NPD207 |
Discontinued |
0.5918 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.5917 |
Remote Similarity |
NPD576 |
Discontinued |
0.5915 |
Remote Similarity |
NPD8105 |
Discontinued |
0.5913 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.5913 |
Remote Similarity |
NPD7465 |
Suspended |
0.5912 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5911 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.5911 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.5902 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.5902 |
Remote Similarity |
NPD4299 |
Phase 1 |
0.5897 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.5897 |
Remote Similarity |
NPD4902 |
Discontinued |
0.5896 |
Remote Similarity |
NPD1451 |
Approved |
0.5896 |
Remote Similarity |
NPD1591 |
Approved |
0.5889 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.5888 |
Remote Similarity |
NPD5827 |
Discontinued |
0.5885 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.5879 |
Remote Similarity |
NPD939 |
Clinical (unspecified phase) |
0.5879 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.5876 |
Remote Similarity |
NPD1690 |
Clinical (unspecified phase) |
0.5865 |
Remote Similarity |
NPD2819 |
Clinical (unspecified phase) |
0.5864 |
Remote Similarity |
NPD2731 |
Phase 2 |
0.5864 |
Remote Similarity |
NPD3041 |
Approved |
0.5859 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.5856 |
Remote Similarity |
NPD6970 |
Phase 2 |
0.585 |
Remote Similarity |
NPD8641 |
Approved |
0.5837 |
Remote Similarity |
NPD7705 |
Clinical (unspecified phase) |
0.5829 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.5829 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.5829 |
Remote Similarity |
NPD2847 |
Phase 2 |
0.5829 |
Remote Similarity |
NPD2222 |
Discontinued |
0.5825 |
Remote Similarity |
NPD1287 |
Phase 2 |
0.5822 |
Remote Similarity |
NPD2813 |
Phase 3 |
0.5822 |
Remote Similarity |
NPD5523 |
Approved |
0.5822 |
Remote Similarity |
NPD2812 |
Clinical (unspecified phase) |
0.5822 |
Remote Similarity |
NPD5524 |
Approved |
0.5822 |
Remote Similarity |
NPD6218 |
Discontinued |
0.582 |
Remote Similarity |
NPD3418 |
Clinical (unspecified phase) |
0.582 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.5816 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.5814 |
Remote Similarity |
NPD6210 |
Phase 3 |
0.5812 |
Remote Similarity |
NPD5843 |
Discontinued |
0.5812 |
Remote Similarity |
NPD2716 |
Discontinued |
0.5808 |
Remote Similarity |
NPD2755 |
Discontinued |
0.5805 |
Remote Similarity |
NPD4924 |
Clinical (unspecified phase) |
0.5802 |
Remote Similarity |
NPD2547 |
Discontinued |
0.5801 |
Remote Similarity |
NPD2180 |
Approved |
0.5797 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.5797 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.5795 |
Remote Similarity |
NPD721 |
Approved |
0.5789 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.5785 |
Remote Similarity |
NPD8159 |
Discontinued |
0.5784 |
Remote Similarity |
NPD3130 |
Discontinued |
0.578 |
Remote Similarity |
NPD3938 |
Phase 1 |
0.5775 |
Remote Similarity |
NPD705 |
Clinical (unspecified phase) |
0.5773 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.5773 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.5771 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.5769 |
Remote Similarity |
NPD1506 |
Discontinued |
0.5769 |
Remote Similarity |
NPD1197 |
Approved |
0.5769 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5766 |
Remote Similarity |
NPD8119 |
Discontinued |
0.5761 |
Remote Similarity |
NPD8504 |
Discovery |
0.5759 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.575 |
Remote Similarity |
NPD1368 |
Approved |
0.5749 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.5746 |
Remote Similarity |
NPD1027 |
Approved |
0.5746 |
Remote Similarity |
NPD1030 |
Approved |
0.5746 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.5746 |
Remote Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.5745 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.5742 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.5742 |
Remote Similarity |
NPD1367 |
Phase 2 |
0.5741 |
Remote Similarity |
NPD6856 |
Discontinued |
0.574 |
Remote Similarity |
NPD6223 |
Clinical (unspecified phase) |
0.5735 |
Remote Similarity |
NPD4863 |
Approved |
0.573 |
Remote Similarity |
NPD775 |
Approved |
0.5728 |
Remote Similarity |
NPD429 |
Approved |
0.5723 |
Remote Similarity |
NPD300 |
Approved |
0.5721 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.5721 |
Remote Similarity |
NPD3460 |
Discontinued |
0.5714 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.5714 |
Remote Similarity |
NPD4187 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD4896 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD5107 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.5708 |
Remote Similarity |
NPD7182 |
Clinical (unspecified phase) |
0.5707 |
Remote Similarity |
NPD1599 |
Approved |
0.5707 |
Remote Similarity |
NPD2536 |
Discontinued |
0.5701 |
Remote Similarity |
NPD2402 |
Approved |
0.5701 |
Remote Similarity |
NPD2401 |
Approved |
0.57 |
Remote Similarity |
NPD6626 |
Approved |
0.5699 |
Remote Similarity |
NPD1288 |
Clinical (unspecified phase) |
0.5696 |
Remote Similarity |
NPD5116 |
Phase 1 |
0.5692 |
Remote Similarity |
NPD1641 |
Discontinued |
0.5691 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.5691 |
Remote Similarity |
NPD1313 |
Approved |
0.5689 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.5689 |
Remote Similarity |
NPD1354 |
Approved |
0.5689 |
Remote Similarity |
NPD1356 |
Approved |
0.5684 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.5683 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.5682 |
Remote Similarity |
NPD724 |
Approved |
0.5682 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.5681 |
Remote Similarity |
NPD7277 |
Approved |
0.5681 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.5681 |
Remote Similarity |
NPD2363 |
Discontinued |
0.5681 |
Remote Similarity |
NPD7276 |
Approved |
0.568 |
Remote Similarity |
NPD6837 |
Clinical (unspecified phase) |
0.568 |
Remote Similarity |
NPD8629 |
Discontinued |
0.5673 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.5673 |
Remote Similarity |
NPD6714 |
Phase 3 |
0.5672 |
Remote Similarity |
NPD3406 |
Suspended |
0.567 |
Remote Similarity |
NPD1893 |
Phase 2 |
0.567 |
Remote Similarity |
NPD1892 |
Phase 2 |
0.567
|
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |